Punnanitinont A, Kramer J
Front Dent Med. 2025; 4:1168645.
PMID: 39916928
PMC: 11797869.
DOI: 10.3389/fdmed.2023.1168645.
Santana E, Dos Santos Ferreira F, Dos Santos Brito W, Lopes F, de Lima A, Neto G
Front Immunol. 2024; 15:1462352.
PMID: 39650644
PMC: 11621001.
DOI: 10.3389/fimmu.2024.1462352.
Dos Santos B, Dos Santos L, Ferreira J, Dos Santos A, Sortica V, de Souza Figueiredo E
Mol Cell Biochem. 2024; .
PMID: 39520513
DOI: 10.1007/s11010-024-05137-3.
Wang F, Dang X, Su H, Lei Y, She C, Zhang C
Mob DNA. 2024; 15(1):23.
PMID: 39427224
PMC: 11490001.
DOI: 10.1186/s13100-024-00335-8.
Punnanitinont A, Biswas S, Kasperek E, Osinski J, Zhu C, Miecznikowski J
Front Cell Dev Biol. 2024; 12:1434269.
PMID: 39310226
PMC: 11413591.
DOI: 10.3389/fcell.2024.1434269.
Safety, pharmacokinetics, biomarker response and efficacy of E6742: a dual antagonist of Toll-like receptors 7 and 8, in a first in patient, randomised, double-blind, phase I/II study in systemic lupus erythematosus.
Tanaka Y, Kumanogoh A, Atsumi T, Ishii T, Tago F, Aoki M
RMD Open. 2024; 10(3).
PMID: 39289029
PMC: 11409405.
DOI: 10.1136/rmdopen-2024-004701.
A Pooled Analysis of Eight Clinical Studies Suggests a Link Between Influenza-Like Symptoms and Pharmacodynamics of the Toll-Like Receptor-7 Agonist Vesatolimod.
Riddler S, Benson C, Brinson C, Deeks S, DeJesus E, Mills A
Infect Dis Ther. 2024; 13(11):2285-2299.
PMID: 39278975
PMC: 11499514.
DOI: 10.1007/s40121-024-01034-w.
Type 2 hypersensitivity disorders, including systemic lupus erythematosus, Sjögren's syndrome, Graves' disease, myasthenia gravis, immune thrombocytopenia, autoimmune hemolytic anemia, dermatomyositis, and graft-versus-host disease, are....
Huang Y, Shih L, Hsieh T, Tsai K, Lu K, Liao M
Virulence. 2024; 15(1):2404225.
PMID: 39267271
PMC: 11409508.
DOI: 10.1080/21505594.2024.2404225.
Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables.
Delgado-Wicke P, Fernandez de Cordoba-Onate S, Roy-Vallejo E, Alegria-Carrasco E, Rodriguez-Serrano D, Lamana A
Sci Rep. 2024; 14(1):20728.
PMID: 39237611
PMC: 11377536.
DOI: 10.1038/s41598-024-71476-2.
Type I Interferons in Systemic Autoimmune Rheumatic Diseases: Pathogenesis, Clinical Features and Treatment Options.
Drougkas K, Skarlis C, Mavragani C
Mediterr J Rheumatol. 2024; 35(Suppl 2):365-380.
PMID: 39193187
PMC: 11345602.
DOI: 10.31138/mjr.270324.tis.
Impact of and gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma.
Obrenovic M, Supic G, Miyabe S, Mladenovic I, Kozomara R, Jovic S
Biomol Biomed. 2024; 24(6):1682-1691.
PMID: 38850110
PMC: 11496855.
DOI: 10.17305/bb.2024.10550.
Two rare UNC93B1 variants contribute to childhood-onset lupus.
Nat Immunol. 2024; 25(6):951-952.
PMID: 38831107
DOI: 10.1038/s41590-024-01850-9.
Genetic variants in UNC93B1 predispose to childhood-onset systemic lupus erythematosus.
Al-Azab M, Idiiatullina E, Liu Z, Lin M, Hrovat-Schaale K, Xian H
Nat Immunol. 2024; 25(6):969-980.
PMID: 38831104
PMC: 11147776.
DOI: 10.1038/s41590-024-01846-5.
Maternal immune activation with toll-like receptor 7 agonist during mid-gestation alters juvenile and adult developmental milestones and behavior.
Sheng J, Tobet S
J Neuroendocrinol. 2024; 36(8):e13417.
PMID: 38822791
PMC: 11296912.
DOI: 10.1111/jne.13417.
Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus.
von Hofsten S, Fenton K, Pedersen H
Int J Mol Sci. 2024; 25(10).
PMID: 38791389
PMC: 11120885.
DOI: 10.3390/ijms25105351.
Associations of toll-like receptor polymorphisms with systemic lupus erythematosus: A meta-analysis.
Lee Y, Song G
Heliyon. 2024; 10(6):e27987.
PMID: 38509975
PMC: 10950724.
DOI: 10.1016/j.heliyon.2024.e27987.
Association of genetic variation on X chromosome with systemic lupus erythematosus in both Thai and Chinese populations.
Tangtanatakul P, Lei Y, Jaiwan K, Yang W, Boonbangyang M, Kunhapan P
Lupus Sci Med. 2024; 11(1).
PMID: 38458775
PMC: 10928741.
DOI: 10.1136/lupus-2023-001061.
Unique pathways downstream of TLR-4 and TLR-7 activation: sex-dependent behavioural, cytokine, and metabolic consequences.
Dunstan I, McLeod R, Radford-Smith D, Xiong W, Pate T, Probert F
Front Cell Neurosci. 2024; 18:1345441.
PMID: 38414751
PMC: 10896997.
DOI: 10.3389/fncel.2024.1345441.
Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update.
Kalliolias G, Basdra E, Papavassiliou A
Biomedicines. 2024; 12(1).
PMID: 38255243
PMC: 10813148.
DOI: 10.3390/biomedicines12010138.
Association of Toll-Like Receptor 7 (TLR7) Polymorphisms with Predisposition to Systemic Lupus Erythematosus (SLE): A Meta and Trial Sequential Analysis.
Ranjan S, Panda A
Biochem Genet. 2023; 62(5):3350-3366.
PMID: 38103124
DOI: 10.1007/s10528-023-10600-9.